Bioreactors Market Size, Growth Trends, Top Players, Application Potential and Forecast to 2030
Bioreactors market report gives attention to market segmentation, market size, and forecast of 2022-2030 to help stakeholders in making a good decision for the future investments. Bioreactors industry report segmented into types, application, and regions with providing production, revenue, import/export.
The bioreactors market landscape is classified into product type, molecule, cell, end-use, usage, and regional landscape.
Browse key industry insights spread across 205 pages with 299 market data tables & 20 figures & charts from the report, “Bioreactors Market Analysis By Product Type (Single-use, Reusable), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Usage (Developmental, Pre-clinical & Clinical, Commercial Production), End-use (R&D Organizations, Biopharma Manufacturers, Contract Manufacturing Organizations [CMOs]), Industry Analysis, Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/bioreactor-market
Based on product type, the bioreactors industry is divided into reusable, and single-use. Among these, reusable product segment is projected to showcase a CAGR of approximately 11.9% from 2022 to 2030, driven by mass production trends encouraging adoption of reusable bioreactors. As they offer better product safety with minimal damage risk to product, vaccine manufacturers are heavily inclined towards adoption of reusable bioreactors for commercial production, thereby offering lucrative scope for segment growth.
By cell, the overall bioreactors market is fragmented into yeast cells, mammalian cells, bacterial cells, and others. Use of bioreactors for processing mammalian cells is expected to scale up during the forecast period to help the mammalian cells segment showcase a CAGR of more than 13.4% over the analysis timeline.
Extensive use of mammalian cells in the development of therapeutic drugs, proteins, and viral vaccines will boost the segment outlook. Moreover, ability of mammalian cells to amplify culture growth of biologics is likely to gain popularity in near future.
In terms of molecule, the industry is categorized into vaccines, gene therapy, monoclonal antibodies, stem cells, recombinant proteins, and others. In 2021, the bioreactors market earned revenues of around $697 million from recombinant proteins segment owing to the favorable biophysical and structural characteristics of the molecule that allow for large-scale production. Increasing focus on recombinant protein technology for better vaccine development will fuel segment growth.
With respect to usage, the bioreactors market is divided into commercial production, and development, preclinical & clinical. In 2021, developmental, preclinical, and clinical segment accounted for approximately 20.8% of total market share. Presence of an extensive pipeline of therapeutics catering to novel drugs and vaccine development will accelerate adoption of bioreactors to aid developmental, preclinical, and clinical phases.
Based on end-use, global bioreactors industry is sectioned into biopharma manufacturers, contract manufacturing organizations (CMOs), and R&D organizations. Among these, contract manufacturing organizations (CMOs) end-use segment contributed over $1 billion in revenue back in 2021, driven by the surging number of CMOs across the globe.
Partial Table of Contents (ToC) of the report:
Chapter 4 Bioreactors Market, By Product Type
4.1 Key segment trends
4.2 Single-use
4.2.1 Market size, by region, 2017-2030 (USD Million)
4.3 Reusable
4.3.1 Market size, by region, 2017-2030 (USD Million)
Chapter 5 Bioreactors Market, By Cell
5.1 Key segment trends
5.2 Mammalian cells
5.2.1 Market size, by region, 2017-2030 (USD Million)
5.3 Bacterial cells
5.3.1 Market size, by region, 2017-2030 (USD Million)
5.4 Yeast cells
5.4.1 Market size, by region, 2017-2030 (USD Million)
5.5 Others
5.5.1 Market size, by region, 2017-2030 (USD Million)
Browse complete table of content of this report @ https://www.gminsights.com/toc/detail/bioreactor-market
About Global Market Insights
Global Market Insights Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us
Arun Hegde
Corporate Sales, USA
Global Market Insights Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: [email protected]